Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
CNN is launching a new “All Access” streaming subscription in the U.S. on October 28th, priced at $6.99 a month, or just $69.99 if you sign up for a full year.
WSJ’s Alexander Gladstone reveals the story behind First Brands’ sudden bankruptcy: hidden deals, corporate chaos, and a mystery that shook the auto world.
Motley Fool’s Bill Mann unpacks October 10th's market chaos, what triggered it, and where smart investors should look next. Don’t miss his expert insight!